Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
31
pubmed:dateCreated
2000-8-24
pubmed:abstractText
To analyse the effect of p53 on liver tumor development, we generated transgenic mice overexpressing wild-type p53 in the liver and crossed them with transgenic mice in which the expression of the SV40 large T antigen (TAg) induces hepatic tumors. Remarkably, whereas preneoplastic TAg liver exhibited anisocaryosis and anisocytosis, TAg/p53 liver never presented any dysplastic cells. Moreover, whereas expression of p53 did not affect hepatic development, its constitutive expression in tumorigenic livers resulted in a significantly enhanced apoptosis once nodules had appeared. In contrast, p53 overexpression did not modify the elevated proliferation of TAg-transformed hepatocytes and had no effect on hepatocarcinoma progression. In vitro analysis of primary hepatocytes exposed to various genotoxic agents showed that p53 failed to sensitize normal or TAg-transformed hepatocytes to apoptosis, except when high doses of doxorubicin, UV-B and UV-C radiation were used. Our results confirmed that the hepatocyte cell type is very resistant to genotoxic agents and showed that constitutive expression of p53 failed to improve their responsiveness. In addition, our results showed that suppression of dysplastic cells, probably by restoring normal cytokinesis and karyokinesis, and enhancement of apoptosis by means of p53 overexpression were insufficient to counteract or delay the TAg-induced liver tumoral progression. Oncogene (2000) 19, 3498 - 3507
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Polyomavirus Transforming, http://linkedlifedata.com/resource/pubmed/chemical/Cdkn1a protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclins, http://linkedlifedata.com/resource/pubmed/chemical/DNA, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Mdm2 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-mdm2, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0950-9232
pubmed:author
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3498-507
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10918608-Animals, pubmed-meshheading:10918608-Antigens, Polyomavirus Transforming, pubmed-meshheading:10918608-Apoptosis, pubmed-meshheading:10918608-Binding Sites, pubmed-meshheading:10918608-Body Weight, pubmed-meshheading:10918608-Cell Line, Transformed, pubmed-meshheading:10918608-Crosses, Genetic, pubmed-meshheading:10918608-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:10918608-Cyclins, pubmed-meshheading:10918608-DNA, pubmed-meshheading:10918608-DNA Damage, pubmed-meshheading:10918608-Disease Progression, pubmed-meshheading:10918608-Doxorubicin, pubmed-meshheading:10918608-Gamma Rays, pubmed-meshheading:10918608-Gene Expression Regulation, pubmed-meshheading:10918608-Gene Expression Regulation, Neoplastic, pubmed-meshheading:10918608-Genes, p53, pubmed-meshheading:10918608-Genotype, pubmed-meshheading:10918608-Hyperplasia, pubmed-meshheading:10918608-Liver, pubmed-meshheading:10918608-Liver Diseases, pubmed-meshheading:10918608-Liver Neoplasms, Experimental, pubmed-meshheading:10918608-Methotrexate, pubmed-meshheading:10918608-Mice, pubmed-meshheading:10918608-Mice, Inbred C57BL, pubmed-meshheading:10918608-Mice, Inbred DBA, pubmed-meshheading:10918608-Mice, Transgenic, pubmed-meshheading:10918608-Nuclear Proteins, pubmed-meshheading:10918608-Organ Size, pubmed-meshheading:10918608-Precancerous Conditions, pubmed-meshheading:10918608-Proto-Oncogene Proteins, pubmed-meshheading:10918608-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:10918608-Proto-Oncogene Proteins c-mdm2, pubmed-meshheading:10918608-Simian virus 40, pubmed-meshheading:10918608-Tumor Suppressor Protein p53, pubmed-meshheading:10918608-Ultraviolet Rays, pubmed-meshheading:10918608-bcl-2-Associated X Protein
pubmed:year
2000
pubmed:articleTitle
The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
pubmed:affiliation
INSERM U380, Institut Cochin de Génétique Moléculaire, 22 rue Méchain, 75014 Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't